'Over-expression of long non-coding RNA ZEB2-AS1 may predict poor prognosis and promote the migration, invasion, and epithelial-mesenchymal transition of tumor cells in non-small cell lung cancer' (vol 35, pg 29, 2020) (Expression of Concern of Vol 35, Pg 29, 2020)

被引:0
|
作者
Xu, H.
Yu, B.
Shen, W.
Jin, C.
Wang, L.
Xi, Y.
机构
来源
关键词
D O I
10.1177/03936155241231135
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:187 / 187
页数:1
相关论文
共 50 条
  • [21] Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells (vol 33, pg 2972, 2015)
    Shi, Jingli
    Liu, Fei
    Zhang, Wenzhang
    Liu, Xin
    Lin, Bihua
    Tang, Xudong
    ONCOLOGY REPORTS, 2023, 50 (04)
  • [22] Long non-coding RNA PITPNA-AS1 silencing suppresses proliferation, metastasis and epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting microRNA-32-5p (vol 23, 212, 2021)
    Chen, Gang
    Zheng, Zhifeng
    Li, Junsheng
    Zhang, Peigang
    Wang, Zhenjun
    Guo, Shiping
    Ma, Jun
    Shen, Jian
    Li, Huixin
    MOLECULAR MEDICINE REPORTS, 2021, 23 (04)
  • [23] Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma (vol 11, pg 2506, 2020)
    Zhang, X.
    Du, L.
    Han, J.
    Li, X.
    Wang, H.
    Zheng, G.
    Wang, Y.
    THORACIC CANCER, 2023, 14 (19) : 1907 - 1907
  • [24] RETRACTION: MicroRNA-200c inhibits the metastasis of non-small cell lung cancer cells by targeting ZEB2, an epithelial-mesenchymal transition regulator (Retraction of Vol 13, Pg 3349, 2016)
    Jiao, Aihong
    Sui, Minghua
    Zhang, Liangming
    Sun, Ping
    Geng, Dongmei
    Zhang, Weiwei
    Wang, Xiuwen
    Li, Junxia
    MOLECULAR MEDICINE REPORTS, 2021, 24 (02) : 573 - 573
  • [25] Long non-coding RNA PITPNA-AS1 silencing suppresses proliferation, metastasis and epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting microRNA-32-5p
    Chen, Gang
    Zheng, Zhifeng
    Li, Junsheng
    Zhang, Peigang
    Wang, Zhenjun
    Guo, Shiping
    Ma, Jun
    Shen, Jian
    Li, Huixin
    Yang, Xiaotang
    MOLECULAR MEDICINE REPORTS, 2021, 23 (03)
  • [26] Epithelial-mesenchymal transition and cancer stem cells, mediated by a long non-coding RNA, HOTAIR, are involved in cell malignant transformation induced by cigarette smoke extract (vol 282, pg 9, 2015)
    Liu, Yi
    Luo, Fei
    Xu, Yuan
    Wang, Bairu
    Zhao, Yue
    Xu, Wenchao
    Shi, Le
    Lu, Xiaolin
    Liu, Qizhan
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2023, 467
  • [27] Long non-coding RNA SDPR-AS affects the development of non-small cell lung cancer by regulating SDPR through p38 MAPK/ERK signals (Expression of Concern of Vol 47, Pg 3172, 2019)
    Zhu, Junfei
    Wang, Lili
    Liao, Ruomin
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2022, 50 (01) : 222 - 222
  • [28] Long Non-Coding RNA LINC00239 Functions as a Competitive Endogenous RNA by Sponging microRNA-484 and Enhancing KLF12 Expression to Promote the Oncogenicity of Colorectal Cancer (Expression of Concern of Vol 13, Pg 12067, 2020)
    Luu, X.
    Yue, M.
    Li, C.
    Sun, D.
    Wang, L.
    ONCOTARGETS AND THERAPY, 2021, 14 : 5055 - 5055
  • [29] RETRACTION: MicroRNA-199b targets the regulation of ZEB1 expression to inhibit cell proliferation, migration and invasion in non-small cell lung cancer (vol 16, pg 5007, 2017) (Retraction of Vol 16, Pg 5007, 2017)
    Wang, Jin
    Zhou, Fachen
    Yin, Liu
    Zhao, Lei
    Zhang, Yixiang
    Wang, Jinguang
    MOLECULAR MEDICINE REPORTS, 2022, 26 (04)
  • [30] UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation (vol 494, pg 121, 2020)
    Yin, Hang
    Wang, Xiaoyuan
    Zhang, Xue
    Zeng, Yangyang
    Xu, Qingyong
    Wang, Wenbo
    Zhou, Fuxiang
    Zhou, Yunfeng
    CANCER LETTERS, 2022, 543